Blood tests for cancer are here, and Guardant Health is leading the charge.
What if a simple blood test at your annual physical could detect cancer in its earliest stages?
Dr. Helmy Eltoukhy, co-founder and co-CEO of Guardant Health, is turning this vision into reality. They’ve seen a spate of FDA approvals. With groundbreaking technologies like Guardant360 and Shield, they're revolutionizing cancer detection and treatment.
Personalis is betting that detecting relapse at the molecular level, before it becomes radiographically obvious, can change how cancer is monitored and managed.
The machinery that governs gene expression is being targeted to beat cancer.
Millions of T1DM patients worldwide are on lifelong insulin and constant monitoring. But what if we could switch off the immune attack causing the disease?
If the disease is in the lungs, why deliver the drugs everywhere else?
